Benzinga | Oct 29, 2021 07:34AM EDT

Wells Fargo Maintains Overweight on Teladoc Health, Raises Price Target to $165

Wells Fargo analyst Stephen Baxter maintains Teladoc Health (NYSE:TDOC) with a Overweight and raises the price target from $156 to $165.